Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

First COVID-19-related clinical trial to start in Germany

German regulators have approved the first clinical trial of a coronavirus vaccine. Developed by BioNTech SE, an immunotherapy company, and Pfizer, a pharmaceutical company, the potential coronavirus vaccine has completed pre-clinical studies in Germany.

24 Apr 2020

Fraunhofer SCAI is opening a new knowledge space with information and analysis tools on COVID-19

With the new website "covid19-knowledgespace.de", Fraunhofer SCAI - together with Fraunhofer IME, Fraunhofer IAIS, the Information Center for Life Sciences ZBMED and other research partners - is opening a new kind of knowledge space with analysis tools and information on COVID-19.

24 Apr 2020

Research looks at best ways to tackle coronavirus crisis

A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.

24 Apr 2020

SARS-CoV-2 targets specific cells in the lung, nasal passage, and intestine

Now, the researchers from the Massachusetts Institute of Technology (MIT) have identified specific types of cells that are targets of the SARS-CoV-2 that causes the COVID-19 pandemic. The findings of the study published in the journal Cell may help in developing novel therapeutics to combat the deadly viral infection.

23 Apr 2020

Coronavirus may cause sudden stroke in younger patients, doctors warn

Older adults and those with underlying medical conditions are at risk of experiencing severe coronavirus disease (COVID-19). Younger people appeared to experience only mild illness, but doctors warn that the viral infection may cause sudden strokes.

23 Apr 2020

A protein discovery could pave way to better treatments for obesity

A USC-led international team of scientists has found the precise shape of a key player in human metabolism, which could lead the way to better treatments for obesity and other metabolic disease.

23 Apr 2020

Minimizing COVID-19 infection through controlled exposure

A new study published in the preprint journal medRxiv in April 2020 explores the possibilities of launching smaller waves of voluntary social exposure in a controlled way, to avoid the occurrence of a single large and probably unmanageable second wave of infection.

23 Apr 2020

Poor quality testing could increase number of COVID-19 infections

A new study published in the preprint open-access journal medRxiv in April 2020 assesses the value of untargeted testing for infection or immunity in COVID-19 vs. high-quality targeted testing in keeping down the number of infections while slowly relaxing lockdown measures.

23 Apr 2020

1.7 billion people at higher risk from COVID-19, study says

The COVID-19 pandemic affecting 185 countries and territories the world over has already claimed over 190,000 lives and sickened well over 2.7 million as of April 24, 2020. Research shows that most of these fatalities are in older people or those who have underlying medical conditions.

23 Apr 2020

Is the confidence in hydroxychloroquine for the management of COVID-19 justified?

A new review paper published in the preprint open-access journal medRxiv in April 2020 reports that there is not enough evidence to justify the widespread use of the drug hydroxychloroquine (HCQ) in the treatment or prophylaxis of the current COVID-19 illness.

23 Apr 2020

Swedes confident with government and media response to coronavirus

A number of groups in Sweden, including public service broadcasters Sveriges Television (SVT), and Sveriges Radio, are providing their country with the latest coverage of the coronavirus situation. A new survey shows that 80% of Swedes have moderate to high levels of trust in the public reporting and their government officials.

23 Apr 2020

U.S. may have to spend hundreds of billions treating COVID-19

A new study published in the journal Health Affairs in April 2020 quantifies the financial and resource burden which could be placed on the U.S. healthcare system at varying levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) community spread.

23 Apr 2020

Low-cost, portable detector takes about 30 minutes to identify pathogens

Most viral test kits rely on labor- and time-intensive laboratory preparation and analysis techniques; for example, tests for the novel coronavirus can take days to detect the virus from nasal swabs.

23 Apr 2020

Abbott’s fast COVID test poses safety issues, lab workers say

Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded - particularly, the risk of infection to those handling it.

23 Apr 2020

RAS inhibitors and COVID-19 severity in hypertensive patients

A new study published in the journal JAMA Cardiology in April 2020 reports that patients with hypertension who are taking medications called ACE inhibitors (ACEI) or ARBs are not at higher risk for death or more severe illness with COVID-19. This conclusion supports current guidelines for the treatment of hypertension during this pandemic.

23 Apr 2020

Link between BCG and lower COVID-19 mortality disproved by new analysis

The association between BCG (Bacillus Calmette-Guérin) vaccination and its purported beneficial effect on COVID-19 transmission/mortality rates was challenged in an expert appraisal of Diamond Princess cruise ship data. At the same time, cross-national differences previously reported were shown to be flawed, reports a new medRxiv study.

23 Apr 2020

New model highlights key measures in curbing local COVID-19 outbreaks

A new decision analytical model published in JAMA Network Open by the researchers from China examined a number of vital epidemiological features of imported severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) cases in the Chinese city of Wenzhou, emphasizing the need for timely community containment.

23 Apr 2020

KHN’s ‘What the Health?’: Whom do we trust for COVID info?

Congress is approving still more money to address the health and economic fallout of the ongoing novel coronavirus pandemic.

23 Apr 2020

Novel method may enable decentralized facilities to deliver faster COVID-19 test services

The COVID-19 pandemic has resulted in over 2.5 million confirmed cases worldwide and nearly over 170,000 deaths as of April 21 according to the World Health Organization.

23 Apr 2020

Study identifies key nose cells as likely COVID-19 virus entry points

Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to get into our cells.

23 Apr 2020